The cash won't stop for Ex­sci­en­tia as it makes a $300M+ Nas­daq de­but

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

An AI biotech with lit­tle hu­man da­ta — but lots of hype — is once again drown­ing in cash.

Ex­sci­en­tia priced its IPO late Thurs­day evening, an­nounc­ing it pulled in $304.7 mil­lion with the raise. The pub­lic de­but marks Ex­sci­en­tia’s third nine-fig­ure raise of the year, af­ter the biotech ex­pand­ed its Se­ries C to $100 mil­lion in March and raised more than half a bil­lion dol­lars in a pair of fi­nanc­ings in April. Ex­sci­en­tia shares will be­gin trad­ing Fri­day at $22 apiece un­der the tick­er $EX­AI.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER